Global Cannabis Applications Corp. announced that Genetica and GCAC will be partnering to create a Definitive Agreement to develop new data insights and better product recommendations to the consumer from intelligence on the plant journey through the supply chain to the consumer, as well as provide feedback recommendations to the grower. Genetica is home to FloraTM, the first AI of its kind for cannabis-derived products.

Flora represents a data pool of over 650 million sources utilized in real time to scientifically select the best product recommendations for individual consumers. GCAC and Genetica agree to a Trade Agreement for the initial data to be valued at USD 120,000 to each party. The partnership will enable both parties to develop a strategic licensing plan to analyze anonymized, jointly transaction-level data to improve recommendations at both ends of the supply chain.

This initiative will focus on retail opportunities in North America, starting with GCAC's offering to Canadian military veterans. Over 15,000 veterans in Canada are licensed to use medical cannabis, with the cost of their prescription, CAD 8.50, covered as per Veterans Affairs' policies. GCAC will be making available data collected from its technologies; Efixii, clearESG and Prescriptii.

Prescriptii is built on an advanced algorithm analyzing over 600,000 verified data points of widely available strains for 80+ medical conditions. Genetica will provide over 100 million data points to be combined with Prescriptii's data to launch the veteran's storefront. In addition, as more veterans use the storefront, Efixii will add cultivation and their feedback data to this stack.

The partnership could see the data points increase to over 600 million within 90 days.